Document K6awjQzZ9M44QdY2g1N7XaEaX

AR226-3137 CONFIDENTIAL SPONSOR ElfAtochemS.A. Cours Michelet La Defense 10 92091 Paris-la-Defense CEDEX France TEST SUBSTANCE STUDY TITLE ACUTE EYE IRRITATION IN RABBITS STUDY DIRECTOR Xavier Manciaux IFM recherche S N.C W WTAL 0 -l ISO 000 f itfCC SOCW :*VSE)U:r IJOHS Evasux as MI w ic.s. r/Hcux STUDY COMPLETION DATE 9 December 1999 PERFORMING LABORATORY err Centre International de Toxicologie BP 563 - 27005 Evreux -France Company Sanitised. Does not contain TSCA CRI LABORATORY STUDY NUMBER 18750TAL CEiMrRE INTERNATIONAL DETWICOLCGIE B. P. 563 27005 Evreux Cedex Tel.: +33 2 32 29 26 26 Fax : +33 2 32 67 87 05 France \^i. if ijtuuy 1'f^. A u / /v i J~I-L.^^^^^^^^^^^^^^^^^^HHL^A i. ^k.i.\^\fj i^iii -.r"^ CONTENTS STATEMENT OF THE STUDY DIRECTOR OTHER SCIENTISTS INVOLVED IN THIS STUDY STATEMENT OF QUALITY ASSURANCE UNIT SUMMARY RESUME 1. INTRODUCTION 2. MATERIALS AND METHODS 2.1 TEST SUBSTANCE 2.1.1 Identification 2.1.2 Formulation procedure 2.2 TEST SYSTEM 2.2.1 Animals 2.2.2 Environmental conditions 2.2.3 Food and water 2.3 TREATMENT 2.3.1 Selection of the animals 2.3.2 Study design 2.3.3 Administration of the test substance 2.3.4 Chronology of the study 2.4 OCULAR EXAMINATIONS 2.5 DESCRIPTION AND EVALUATION OF OCULAR REACTIONS 2.5.1 Conjunctival lesions and discharge 2.5.2 Iris lesions 2.5.3 Comeal lesions . . 2.6 INTERPRETATION OF RESULTS AND CLASSIFICATION OF SUBSTANCES 2.6.1 Interpretation of the results , 2.6.2 Classification of the test substances 2.7 PROTOCOL ADHERENCE 2.8 ARCHIVING 3.RESULTS . 4. CONCLUSION 4 4 5 6 7 8 10 10 10 10 10 10 11 11 11 11 12 12 12 13 13 14 14 ^oftlpanySsnItlae'd. 'Doas not ~n'a;- -re^ \ <^a, X^A A./ LJLUUV 1 ^U. 1 U f -/V J- J LL-^^^^^^^^^^^^^^^^^^^^B^** - kkw Table 1: Individual ocular examinations and mean values of the scores recorded at each reading (24, 48 and 72 hours) for each animal 15 ,i ' APPENDICES 16 1. Test article description and analytical certificate 2. Diet formula 17 20 and 21 Company Sanitized. Does not contain TSCA CBl \^A A/hJLULLJT nw. 1U/./V 4.4 STATEMENT OF THE STUDY DIRECTOR The study was performed in compliance with the principles of Good Laboratory Practice as described in: . OECD Principles on Good Laboratory Practice (as revised in 1997), ENV/MC/CHEM (98)17. . Decret N 90-206 du 7 mars 1990 concemant les Bonnes Pratiques de Laboratoire (Journal Officiel du 9 mars 1990), Ministere de llndustrie et de 1'Amenagement du Temtoire. . Council Directive 87/18/EEC of 18 December 1986 on the hannonization of laws, regulations or administrative provisions relating to the application of the Principles of Good Laboratory Practice and the verification of their applications for tests on chemical substances (OJ No. L 15 of 17.1.87). I declare that this report constitutes a true and faithful record of the procedures undertaken and the results obtained during the performance of the study. This study was performed at CIT, Centre International de Toxicologie, BP 563, 27005 Evreux, France. Toxicology X. Manciaux Study Director Doctor of Pharmacy Date: 9 December 1999 OTHER SCIENTISTS INVOLVED IN THIS STUDY For Pharmacy: P.O. Guillaumat Docter of Pharmacy For Toxicology: C. Pelcot Study Supervisor jSofttpany Sanitizsc. Does not conta^ TSCA W. STATEMENT OF QUALITY ASSURANCE UNIT Type of inspections Protocol Report Inspections 4 June 1999 10 November 1999 Dates Reported to Study Director (*) 4 June 1999 7 December 1999 Reported to Management (*) 4 June 1999 7 December 1999 In addition to the above-mentioned inspections, at about the same time as the study described in the present report, "process-based" and routine facility inspections of critical procedures relevant to this study type were also made by the Quality Assurance Unit. The findings of these inspections were reported to the Study Director and to CIT Management. The inspections were performed in compliance with CIT Quality Assurance Unit procedures and the Good Laboratory Practice. The reported methods and procedures were found to describe those used and the results to constitute an accurate and complete reflection of the study raw data. OAc&^T^S L. Valette-TaIbi Date: 9 December 1999 Doctor of Biochemistry Head of Quality Assurance Unit and Scientific Archives (*) The dates indicated correspond to the dates of signature of audit reports by Study Director and Management. '..t^^^.. .-</t .'-i0^ C-*1/-*^^*"* i ^*^- r SUMMARY HI^H^HHIHUlto "according s^)^l^tochemSA_^ans-la-Defense, France, the potential of the test substance induce ocular irritation was evaluated in rabbits to OECD (No. 405, 24th February 1987) and EC (92/69/EEC, B.5. 31st July 1992) guidelines. The study was conducted in compliance with the principles of Good Laboratory Practice Regulations. Methods The study design was established according to available information on the test substance and the above guidelines. As no irritant effects were anticipated, a single dose of 0.1 ml of the undiluted test substance was instilled into the conjunctival sac of the left eye of three male New Zealand White rabbits. The right eye was not treated and served as control. The eyes were not rinsed after administration of the test substance. Ocular reactions were observed approximately 1 hour, 24, 48 and 72 hours after the administration. The mean values of the scores for chemosis, redness of the conjunctiva, iris lesions and comeal opacity were calculated for each animal. Results No ocular reactions were observed during the study. Mean scores calculated for each animal over 24, 48 and 72 hours were 0.0, 0.0 and 0.0 for chemosis, 0.0, 0.0 and 0.0 for redness of the conjunctiva, 0.0,0.0 and 0.0 for iris lesions and 0.0, 0.0 and 0.0 for comeal opacity. Conclusion Under our experimental conditions, the test substanceJHHIHHHMB||U|HII|is non-irritant when administered by ocular route to rabbits. According to the classification criteria laid down in Commission Directive 93/2 I/EEC (27th April 1993) adapting to technical progress for the eighteenth time Council Directive 67/548/EEC, the test substance is considered non-irritant. 'Company Sanitized. Does not contain TSCA CBI RESUME A la demande de Elf Atochem S.A., Paris-la-Defense, France, les proprietes iiritantes oculaires du produiiy^BU^^^|^m^H|HHapres application unique chez Ie Lapin ont ete evaluees saonlesli^iesdirecttice'derOCDE (n405, 24fevrier 1987) et de la CEE (92/69/EEC, B.5, 31 juillet 1992). L'etude a ete realisee conformement aux regles de Bonnes Pratiques de Laboratoire. Methode L'etude a ete realisee selon les informations disponibles sur Ie produit et les lignes directrices mentionnees ci-dessus. Aucun effet irritant n'etant suppose, une dose unique de 0,1 ml de produit non dilue a ete instillee dans Ie cul de sac conjonctival de 1'oeil gauche de 3 lapins males New Zealand White. L'oeil droit n'a pas ete traite et a servi de temoin. Aucun rinsage des yeux n'a ete realise apres 1'administration du produit. Les reactions oculaires ont ete observees environ 1 heure, 24, 48 et 72 heures apres 1'administration. La moyenne des scores pour Ie chemosis, la rougeur de la conjunctive, les lesions de 1'iris et 1'opacite de la comee a ete calculee pour chaque animal. Resultats Aucune reaction oculaire n'est observee pendant 1'etude. La moyenne des scores enregistres pour chaque animal apres 24, 48 et 72 heures est de 0,0; 0,0 et 0,0 pour Ie chemosis, 0,0; 0,0 et 0,0 pour la rougeur de la conjonctive, 0,0; 0,0 et 0,0 pour les lesions de 1'iris et 0,0 ; 0,0 et 0,0 pour 1'opacite comeenne. Conclusion Dans nos conditions experimentales, Ie produi non irritant par voie oculaire chez Ie Lapin. ^^ g Selon les criteres de classification decrits dans la Directive 93/21/CEE (27 avril 1993) portant dix-huitieme adaptation au progres technique de la Directive 67/548/CEE, Ie produit est considere non irritant. Safipany SawtizR'd. Does hot COTIW-' Tft^ff. ^w '^-ii/^luuj nu. A u /-/v 1.^1 1. INTRODUCTION The objective of this study was to evaluate the potential of the test substance induce irritation following a single ocular administration in rabbits. 4. In the assessment of the toxic characteristics of a test substance, determination of the irritant effects on the eyes of mammals is an important initial step. Information derived from this test serves to indicate the possible hazards likely to arise from exposure of the eyes. and associated mucous membranes, to the test substance. This study was conducted in compliance with: . OECD guideline No. 405,24th February 1987, . EC Directive No. 92/69/EEC, B.5, 31st July 1992. 2. MATERIALS AND METHODS 2.1 TEST SUBSTANCE The test substancejMBH^IHused in the study was supplied by Elf Atochem S.A. The test substance was identified as follows: - protocol and labellingBBMUB^B \ . batch number: ^^^^---- - protocol and labelIinglflU^ Elf Atochem filing number 1392/99 . description: amber liquid . container: one smoked glass flask . date of receipt: 5 May 1999 . storage conditions: at room temperature and protected from light . expiry date: May 2000. Data relating to the characterization of the test substance are documented in a test article description and an analytical certificate (presented in appendix 1) provided by the Sponsor. The pH of the test substance, as mentioned on the test article description, was 5 1. .: f 2.1,2 Formulation procedure The test substance was used undiluted. 2.2 TEST SYSTEM 2.2.1 Animals Sex, species, strain: male New Zealand White rabbits. Reason for this choice: species generally accepted by regulatory authorities for this type of study. Breeder: Elevage des Dombes, 01400 Chatillon-sur-Chalaronne, France. Number of animals: three animals were used, as recommended by the international guidelines. Identification: the animals were identified individually with a metal ear tag. Weight: on the day of treatment, the animals had a mean body weight standard deviation of 3.0 0.1 kg. Acclimatization: at least 5 days before the beginning of the study. 2.2.2 Environmental conditions The conditions in the animal room were set as follows: .temperature: 183C . relative humidity: 30 to 70% . light/dark cycle: 12h/12h . ventilation: approximately 12 cycles/hour of filtered, non-recycled air. The temperature and relative humidity were under continuous control and recording. The records were checked daily and filed. In addition to these daily checks, the housing conditions and corresponding instrumentation and equipment were verified and calibrated at regular intervals. The animals were housed individually in polystyrene cages (48.2 cm x 58 cm x 36.5 cm). Each cage was equipped with a food container and a water bottle. i 2.2.3 Food and water During the study, the animals had free access to 112 C pelleted diet (UAR, 91360 Villemoissonsur-Orge, France). Each batch of food was analysed by the supplier for composition and contaminant levels. The diet formula is presented in appendix 2. Drinking water filtered by a FG Millipore membrane (0.22 micron) was provided ad Ubitum. Bacteriological and chemical analyses of the water and diet, including the detection of possible contaminants (pesticides, heavy metals and nitrosamines), are performed regularly by external laboratories. The results of these analyses are archived at dr. No contaminants were known to have been present in the diet or drinking water at levels which may be expected to have interfered with or prejudiced the outcome of the study. SC.OmpanSyanitized. Does not constn TP/*-- 23 TREATMENT 2.3.1 Selection of the animals The day before treatment, the eyes of each animal were examined in order to use only animals without any signs of ocular lesions. Animals showing signs of ocular irritation, ocular defects or pre-existing comeal injury were not used. 2.3.2 Study design The study design was established according to available information on the test substance and according to the OECD (No. 405) and EC (92/69/EEC, B.5) guidelines. As no irritant effects were anticipated, the test substance was evaluated in three animals. 2.3.3 Administration of the test substance A single dose of 0.1 ml of the undiluted test substance was instilled into the conjunctival sac of the left eye after gently pulling the lower lid away from the eyeball. The lower and upper eyelids were held together for about one second to avoid any loss of test substance. The right eye, which remained untreated, served as control. The eyes were not rinsed after administration of the test substance. 2.3.4 Chronology of the study Date of treatment (day 1) End of the observation period 900 15 July 1999 18 July 1999 47 15 July 1999 18 July 1999 48 15 July 1999 18 July 1999 2.4 OCULAR EXAMINATIONS - The eyes were examined approximately 1 hour, 24, 48 and 72 hours after administration of the test substance. Following the OECD and EC guidelines: . when there was no evidence of irritation after 72 hours, the study was ended. . when there was persistent ocular irritation after 72 hours, the observation period was extended to a maximum of 21 days (until day 22) in order to determine the progress of the lesions and their reversibility. . when severe irritant effects were observed, the animals were killed on humane grounds. Any change in the animals' behaviour was noted. g-am^.w"0"01'1'""'1'0"" 2.5 DESCRIPTION AND EVALUATION OF OCULAR REACTIONS Ocular reactions were evaluated for each animal according to the following numerical scale: 2.5.1 Conjunctival lesions and discharge Chemosis (lids and/or nictitating membranes) . no swelling............................................................................................................................... 0 . any swelling above normal (includes nictitating membranes)................................................. 1 . obvious swelling with partial eversion of lids......................................................................... 2 . swelling with lids about half-closed........................................................................................ 3 . swelling with lids more than half-closed................................................................................. 4 Redness (refers to palpebral and bulbar conjunctivae, cornea and iris) . blood vessels normal............................................................................................................... 0 . a number of blood vessels definitely hyperemic (injected)..................................................... 1 . diffuse, crimson colour, individual vessels not easily discernible........................................... 2 . diffuse, beefy red..................................................................................................................... 3 Discharge . absence of discharge................................................................................................................ 0 . slight discharge (does not include small amounts normally found in inner canthus).......................................................................................................................... 1 . discharge with moistening of lids and hairs adjacent to lids................................................... 2 . discharge with moistening of lids and hairs on wide area around the eye............................... 3 2.5.2 Iris lesions 0 . normal...................................................................................................................................... . markedly deepened rugae, congestion, swelling, moderate circum-comeal hyperemia, or injection, any of these or combination of any thereof, iris still reacting to light (sluggish reaction is positive)........................................................................ 1 . no reaction to light, haemorrhage, gross destruction (any or all of these)............................... 2 2.5.3 Comeal lesions Cornea (direct examination or, if necessary, with an Ultra-Violet lamp) To determine the presence or absence of comeal opacification and to evaluate the affected area, one or two drops of 0.5% sodium fluorescein solution can be instilled into the eye (however, this must not be performed before the 24-hour reading). If comeal opacification is difficult to determine, the eye can be examined under a UV lamp (a clear fluorescence is visible in the areas of opacification). Opacity (degree of intensity: area most dense taken for reading) . no ulceration or opacity...........................................................................--.............--............. 0 . scattered or diffuse areas of opacity (other than slight dulling or normal lustre), details of iris clearly visible..................................................................................................... 1 . easily discernible translucent area, details of iris slightly obscured........................................ 2 . nacrous areas, no details of iris visible, size of pupil barely discernible................................. 3 . opaque cornea, iris not discernible through the opacity.......................................................... 4 ^Al/tJtUUY L^U. 1U/^/\/ A J- Area of opacity . one quarter (or less) but not zero......................... . greater than one quarter but less than a half ........ . greater than one half but less than three quarters . greater than three quarters up to whole area......... Any other lesions observed were noted. 2.6 INTERPRETATION OF RESULTS AND CLASSIFICATION OF SUBSTANCES The results obtained were evaluated in conjunction with the nature and the reversibility of the scores observed, whilst taking into account all the reactions of the treated animals. Classification of the test substance is based on the criteria laid down in Commission Directive 93/2 I/EEC of 27 April 1993 adapting to technical progress for the eighteenth time Council Directive 67/548/EEC on the approximation of the laws, regulations and administrative provisions relating to the classification, packaging and labelling of dangerous substances. 2.6.1 Interpretation of the results Criteria for irritation A substance or a preparation is considered irritant for the eyes if, when applied to the eye of the animal, significant severe ocular lesions are caused within 72 hours after exposure and which persist for 24 hours or more after treatment with the test substance. All the scores at each reading time (24, 48 and 72 hours) and for an effect are used for calculating the respective mean values. 2.6.2 Classification of the test substances - Xi symbol, indication of danger "irritant", - phrases indicating the nature of special risks: R 36: "Irritating to eyes" Ocular lesions are significant if the mean score has any of the following values: . opacity of the cornea > 2, but < 3, lesion of the iris > 1, but <. 1.5, .. redness of the conjunctivae S 2.5, . . oedema of the conjunctivae (chemosis) S 2. Or else, if the test is performed on three animals, if at least two of them show lesions equal to one of the following values: . opacity of the cornea S 2, but < 3, . lesion of the iris > 1, but < 2, . redness of the conjunctivae > 2.5, . oedema of the conjunctivae (chemosis) S 2. ICompanySanitized. Does not contain TSCA CB1 R 41: "Risk of serious damage to eyes" Ocular lesions are severe: if the mean score has any of the following values: . opacity of the cornea > 3, . lesion of the iris > 1.5. Or else, if the test is performed on three animals, if at least two of them show lesions equal to one of the following values: . opacity of the cornea > 3, . lesion of the iris = 2. Or if they persist at the end of the observation period. If the test substance or preparation induces irreversible colouration of the eyes, the phrase R 41 should also be applied. 2.7 PROTOCOL ADHERENCE The study was performed in accordance with Study Protocol No. 18750 TAL and subsequent amendments, with the following deviations from the agreed Study Protocol: . the temperature and relative humidity recorded in the animal room were sometimes outside of the target ranges specified in the protocol. These minor deviations were not considered to compromise the validity or integrity of the study. 2.8 ARCHIVING The study documentation and specimens generated during the course of the study are archived at Crr, 27005 Evreux, France, for 10 years after the end of the in vivo phase of the study. The archived study materials include: . protocol and possible amendments, . raw data, . correspondence, . final report and possible amendments. On completion of this period, the archived study materials will be returned to the Sponsor, or may be archived at CIT for a further period. panxSann5zed. Ooes not contain TSCACSi 3. RESULTS The observations recorded during the study are presented in table 1. No ocular reactions were observed during the study. Mean scores calculated for each animal over 24, 48 and 72 hours were 0.0, 0.0 and 0.0 for chemosis, 0.0, 0.0 and 0.0 for redness of the conjunctiva, 0.0,0.0 and 0.0 for iris lesions and 0.0, 0.0 and 0.0 for comeal opacity. 4. CONCLUSION Under our experimental conditions, the test substance^|HH|H^BI^|^^HiBUB|is non-irritant when administered by ocular route to rabbits. "-- According to the classification criteria laid down in Commission Directive 93/2 I/EEC (27th April 1993) adapting to technical progress for the eighteenth time Council Directive 67/548/EEC, the test substance is considered non-irritant. Table 1: Individual ocular examinations and mean values of the scores recorded at each reading (24, 48 and 72 hours) for each animal Rabbit number Region of eye 900 Conjunctivae Description of ocular reactions Ih Dl Chemosis 0 Redness 0 SIcores 24h 48h D2 D3 0 0 0 0 Mean Interpretation irritation (+) 72h score(1) (-) D4 0 0.0 (-) 0 0.0 (-) Discharge 0 0 0 0 0.0 Iris 0 0 0 0 0.0 Comeal opacity Intensity 0 0 0 0 0.0 Area 0 0 0 0 0.0 (-) ' (-) Other * * * Fluorcscein / U / / 47 Conjunctivae Chcmosis 0 0 0 0 0.0 (-) Redness 0 0 0 0 0.0 (-) Discharge 0 0 0 0 0.0 Iris 0 0 0 0 0.0 (-) Comeal opacity Intensity 0 0 0 0 0.0 (-) Area 0 0 0 0 0.0 Other 4 Fluorescein / U / / 48 Conjunctivae Chemosis 0 0 0 0 0.0 (-) Redness 0 0 0 0 0.0 (-) Discharge 0 0 0 0 0.0 Iris 0 0 0 0 0.0 (-) Comeal opacity Intensity 0 0 0 0 0.0 (-) Area 0 0 0 0 0.0 Other Fluorescein / U / 1 (1) mean of scores on days 2.3 and 4 h -hour D -day (+) " irritant according to E.E.C. criteria (-) - non-irritant according to E.E.C. criteria * - None / - Fluorescein not used U - Fluorescein batch No. 7239 ICpmpanySanitized. Does nol contain TSCA CBI APPENDICES ^'-pffipan^iSaniisaed.Ooss no', contain TSCA Cti ^ii/tiluuy iw. louu i 1. Test article description and analytical certificate TOXICOLOGY DEPARTMENT CONFIDENTIAL April 99 elf atochem s.a, La defense 10, cours Michelet 92091 Paris-la-Defense, France TEST ARTICLE DESCRIPTION PHYSICAL AND CHEMICAL PROPERTIES Appearance pH !Density Boiling point Flash point Solubility amber liquid 51 HOOkg/m3 at20C 98-100C no flash point water: insoluble soluble in alcohols, aromatic hydrocarbons TOXICOLOGICAL INFORMATIONS AND USE SAFETY See safety data sheet STORAGE AND DISPOSAL Storage Expiry date Disposal __ : in dark and at room temperature : may 2000 : incineration ^--i i/ k>LUUjr i^^. iy/-/^ n t^ A v*vj ^ < *- ..--..,.,,-. . ,,,,,.._.-. --.- -. eiF atochem GS@ /--\r--^^>. Elf Atochem S.A. Usino da Vaiera-Sainl-Paul ZA VMara Saint Paii - Rieux B.P. 20-60870 Ricux (Franco) T41: 74..74 . Fix : w.7<.<2.07 T<lt: IdO <2' ATO VSP Villcra SaSat Paul, It 9 Novcmbrc 1999 .f LotN Extrait Sec Tcrtio Butanol Acrylainide Acidc acryliquc Test d'cxtinction Unit6 % % % % I R6sulLat 30,3 Specification dc fabrication 29131 Mdthodc d'xnalysc LCU 622 0.95 Oil LCU 653 0.07 OAO.l LCU 658 0.1 0^2 LCU 658 positif positif SA1021 Le Chcrde Scmce du Labornloirc .VCWATUIU::: H0,\f : Rohcrt Gnipfw BSompOTySanir.zed.DoesnolconlalnTBCA .-_ ^""'^-|| l-pital 3 W - ---. -. --- - 12J 5DOFraon . ar.v. >J_i_,,<i R ." " "y> '"W <--A, A / OLUUJT l^U. I U I ~t\J A ^ ' -< A ^^AV^ LA rl.S^ A & A VI J^rA A A Afcw^ilb 2. Diet formula [^^pan^ ISaniiixed, Dues not contain TSCA Cfe' v-i. i/jluuj itu. i o / -/v i, r~i-*-rf A ^A Ref:112 COMPLETE DIET RABBIT MAINTENANCE DIET Appearance: 4.5 nun diameter granules Conditioning: bags of 25 kgs Daily portion: in accordance with race and body weight. Rabbits 100-150 g, water ad libitum. FORMULA % Cereals ...................................... Grain byproducts and legumes. Vegetable protein (soya bean meal, yeast) .............................. Vitamin and mineral mixture.... AVERAGE ANALYSIS % Calorific value (Kcal/kg). Moisture........................ Proteins............................ Lipids............................... Carbohydrates (N.F.E.) Fibre................................. Minerals (ash) .................. AMINO ACID VALUES (calculated in mg/kg) Arginine..... Cystine ....... Lysine ........ Methionine. Tryptophan. Glycine....... FATTY ACID VALUES (calculated in mg/kg) Palmitic acid ..... Palmitoleic acid Stearic acid........ Oleic acid........... Linoleic acid ...... Linolenic acid.... 43.8 49 4.2 3 2200 10 13 2.7 49.3 17 MINI3RALS (calculated in mg/kg) Nat. CMV val. val. . Total P..................... .. Ca ................. K ................... Na ................. Me 3500 4500 11600 400 2100 3500 4500 0 1600 100 7000 9000 11600 2000 2200 Mn ................ Fe................... Cu ................. Zn ................. Co .................. I Cl..................... ................... 40 160 12 30 0.1 0 500 40 140 15 45 1.5 0 3000 80 300 27 75 1.6 0 3500 8 6800 2100 4600 1600 1400 5200 6400 0 600 6400 vmdiMINS (calc:ulated per kg) Nat. CMV Vitamin A Vitamin D3 val. 2850 IU 30 IU val. 6500 IU 1000 IU Vitamin B 1 Vitamin B2 Vitamin B3 Vitamin B6 Vitamin B 12 Vitamin E Vitamin K3 Vitamin PP Folic acid 4.3 mg 3.8 mg 16 mg 1 mg Omg 16 mg 6mg 55 mg Omg Omg Omg Omg 1 mg Omg 10 mg 1 mg 5mg Omg Biotin Choline Omg 850 mg Omg 200 mg vieso-lnositol Omg Omg Total 9350 IU 1030IU 4.3 mg 3.8 mg 16 mg 2mg Omg 26 mg 7-mg 60 mg Omg Omg 1050 mg Omg 12100 2400 Available under quality "Control Ref.: 112 C" UAR, 7 rue Gallieni, 91360 Villemoisson - Tel: 01.69.04.03.57 - Fax : 01.69.04.81.97 (Ref. Doc. UAR : 1992)